Skip to main content
. 2015 Feb 4;6(1):56–74. doi: 10.4338/ACI-2014-10-RA-0087

Table 2.

Frequency table for criteria in the first decision step of the model created from patient data and their levels.

Criteria Frequency Percent
Stage of disease
T1N0M0 11 2.8
T1N2M0 1 0.3
T2N0M0 28 7.2
T2N0M1 2 0.5
T2N1M0 11 2.8
T2N2M0 3 0.8
T3N0M0 58 14.9
T3N0M1 7 1.8
T3N1M0 68 17.5
T3N1M1 11 2.8
T3N2M0 52 13.4
T3N2M1 8 2.1
T3N3M1 1 0.3
T4N0M0 28 7.2
T4N0M1 1 0.3
T4N1M0 39 10.1
T4N1M1 2 0.5
T4N2M0 42 10.8
T4N2M1 13 3.4
T4N3M0 1 0.3
T4N3M1 1 0.3
Location of the tumor
Lower 153 39.4
Middle 153 39.4
Upper 82 21.1
Coexisting disease or pathology
Present 121 31.2
• DMa 17 4.4
• DM+HTb 13 3.4
• DM+CADc 4 1.0
• DM+CAD+HT+Other 1 0.3
• DM+COPDd 1 0.3
• DM+COPD+HT 1 0.3
• HT 44 11.3
• HT+Other 2 0.5
• HT+CKFe 2 0.5
• CAD 9 2.3
• CAD +HT 3 0.8
• CKF 4 1.0
• COPD 12 3.1
•COPD+HT 2 0.5
•COPD+CAD 1 0.3
• CLFf 1 0.3
• Other 4 1.0
Absent 267 68.8
Invasion of adjacent organs
Present 46 11.9
Absent 342 88.1
Surgeon’s experience
Lower than 20 43 11,1
Equal or upper than 20 345 88,9
Presence of perforation
Present 0 0
Absent 388 100.0
Presence of obstruction
Present 0 0
Absent 388 100.0
Presence of fistula
Present 0 0
Absent 388 100.0

aDM: Diabetes mellitus;

bHT: Hypertension;

cCAD: Coronary artery disease;

dCOPD: Chronic obstructive pulmonary disease;

eCKF: Chronic kidney failure;

fCLF: Chronic liver failure